UL stock forecast, quote, news & analysis

Key Takeaways

• Unilever shares closed at $60.94 on July 24, 2026, reflecting a modest gain of less than 1% over the trailing 30-day period, as the stock consolidates near its 50-day moving average of approximately $58.85.
• The company is in the midst of the most significant portfolio transformation in its history — spinning off its ice cream division in December 2025 and agreeing to combine its Foods business with McCormick in spring 2026.
• Q1 2026 underlying sales grew 3.8% year-over-year, driven by 2.9% volume growth, with Power Brands delivering 5.0% growth and emerging markets leading the way.
• Q2 2026 earnings are scheduled for July 28, with analysts forecasting underlying sales growth of approximately 4.3% and turnover near €12.9 billion.
• Analyst sentiment is mixed but leans cautiously positive, with a consensus Hold-to-Buy rating and price targets ranging from approximately $61 to over $69 on the NYSE-listed shares.
• The McCormick foods combination, expected to close by mid-2027, will reshape Unilever into a pure-play Home and Personal Care company with roughly €39 billion in revenue.

Current Market Snapshot

Unilever PLC shares have traded within a relatively tight range over the past 30 days, moving between approximately $59.90 and $62.71 as the market digests the company's sweeping structural overhaul. The stock closed at $60.94 on July 24, 2026, holding above its 50-day simple moving average of $58.85 but remaining below its 200-day moving average of roughly $62.45. The 52-week range of $54.75 to $74.97 underscores the stock's volatility over the past year as Unilever executes one of the most ambitious portfolio resets in the consumer staples sector. With second-quarter earnings due July 28, investors are weighing the promise of a more focused, higher-growth Home and Personal Care (HPC) pure-play against execution risks tied to the planned Foods combination with MKC and broader macroeconomic uncertainty.

Unilever (UL) Business Overview and Competitive Position

Unilever PLC is one of the world's largest fast-moving consumer goods companies, with products used by an estimated 3.4 billion people daily across more than 190 countries. The company's portfolio is anchored by roughly 30 Power Brands — including Dove, Vaseline, Rexona, Hellmann's, Knorr, Domestos, and Cif — which together account for approximately 78% of group turnover. Following the December 2025 demerger of The Magnum Ice Cream Company and the spring 2026 agreement to combine its Foods division with McCormick, Unilever is transitioning toward a streamlined HPC-focused business centered on Beauty & Wellbeing, Personal Care, and Home Care. The company derives over 60% of its post-foods revenue from emerging markets, with India, Latin America, and Southeast Asia serving as critical growth engines alongside a premiumization push in North America. Unilever's competitive strengths include unparalleled emerging-market distribution, a portfolio of trusted household brands, and an accelerating productivity program that has already delivered €750 million of a targeted €800 million in savings.

Recent Developments Driving UL

The most consequential development shaping Unilever's narrative is the agreement to combine its Foods business — home to Knorr and Hellmann's — with U.S.-based McCormick, creating a scaled global flavor company reportedly valued at approximately $45 billion. Unilever shareholders will retain a 65% stake in the combined entity, which is expected to generate approximately $600 million in annual cost synergies. The deal, announced in March 2026 and expected to close by mid-2027, will leave Unilever as a pure-play HPC business with roughly €39 billion in revenue and a structurally higher growth profile.

On the operational front, Q1 2026 results posted on May 1 showed underlying sales growth of 3.8%, with volumes up 2.9% — marking the ninth consecutive quarter of volume-led growth. Home Care was the standout segment with 6.1% underlying sales growth and 6.2% volume growth, driven by strong performances in India and Brazil. Emerging markets grew 5.7%, with India accelerating to 7% growth, while developed markets grew a more muted 1.0%, weighed down by subdued European consumer demand.

On the capital allocation front, Unilever launched a €1.5 billion share buyback in Q1, raised its quarterly dividend by 3% to €0.4664 per share, and completed several bolt-on transactions — including the acquisition of U.S. supplements brand Grüns. Meanwhile, senior executives, including CFO Srinivas Phatak, reinvested cash dividends into additional shares in early July, signaling management's confidence in the long-term strategy.

Analyst actions have been mixed. Barclays and Bernstein maintain Buy ratings with price targets of 5,700 GBp and 5,800 GBp respectively, citing the growth potential of a focused HPC portfolio. Jefferies, however, reiterated an Underperform/Sell rating with a 3,800 GBp target, citing concerns about soft volume trends in North America's wellness brands and a valuation that appears rich relative to growth. On the NYSE, the consensus analyst target price stands at approximately $68.21, implying roughly 12% upside from current levels, with five analysts polled by S&P Global assigning a consensus Buy rating.

Trending AI Robots

Investors seeking data-driven strategies can explore Tickeron's Trending AI Robots page, which curates a selection of top-performing AI-powered trading bots from a universe of hundreds of available algorithms covering thousands of tickers. Each bot operates with a distinct strategy, timeframe, and risk profile — ranging from short-term momentum plays to longer-duration trend-following models — and only those demonstrating consistent, verifiable performance metrics earn placement in this curated section. For traders looking to complement fundamental analysis with quantitative signals, the Trending AI Robots page offers a window into how algorithmic strategies are navigating current market conditions across diverse sectors and asset classes.

2026 Outlook and What Investors Should Watch

The immediate catalyst for Unilever is the Q2 2026 earnings report on July 28, where investors will scrutinize volume momentum, margin trends, and updates on full-year guidance. Management has guided for underlying sales growth at the lower end of the 4%–6% multi-year range, with at least 2% volume growth and a modest improvement in underlying operating margin from the 20.0% base achieved in 2025.

Beyond earnings, the trajectory of the McCormick foods combination remains the dominant structural story. Key milestones include regulatory approvals, McCormick shareholder approval, and the confirmation of final transaction terms. Investor attention will also focus on stranded-cost mitigation — Unilever expects €400–500 million in stranded costs post-separation, to be offset through 2029 — and on how quickly the remaining HPC business can re-accelerate growth.

Macroeconomic factors warrant close monitoring. Unilever flagged higher-than-expected input-cost inflation of €750–900 million for 2026, concentrated in Home Care and emerging markets, which may require selective pricing actions. Currency headwinds, which reduced reported turnover by 7.7% in Q1, are expected to remain a drag. On the demand side, emerging-market strength — particularly in India — provides a counterbalance to European softness, while FIFA World Cup sponsorships are expected to support Personal Care volumes in the second half. The Capital Markets Day scheduled for November 4, 2026, will offer a more detailed roadmap for the post-foods Unilever and represents a pivotal event for long-term investors.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations